Evaluation of DNA-targeted anti-cancer drugs by Raman spectroscopy

[1]  M. Caruso,et al.  Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: the state of the art. , 2006, Cancer treatment reviews.

[2]  J. Aaron,et al.  Fluorescence studies of anti-cancer drugs--analytical and biomedical applications. , 2006, Current drug targets.

[3]  Elke S. Bergmann-Leitner,et al.  Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner] , 2005 .

[4]  G. Song,et al.  The fluorescence studies of interaction between 4-(n-2′-glucosyl) butyramidyl triphenyl phosphonium chloride and DNA , 2004 .

[5]  K. Dunbar,et al.  Unprecedented head-to-head conformers of d(GpG) bound to the antitumor active compound tetrakis (mu-carboxylato)dirhodium(II,II). , 2003, Journal of the American Chemical Society.

[6]  D. Rideout,et al.  Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria. , 2002, Cancer research.

[7]  C. Trentesaux,et al.  Synthesis and antiproliferative activity of [2-(phthaloylamino)alkyl]triphenyl phosphonium derivatives against K562 cell line , 2001, Anti-cancer drugs.

[8]  D. Rideout,et al.  1H NMR visible lipids are induced by phosphonium salts and 5‐fluorouracil in human breast cancer cells , 2001, Magnetic resonance in medicine.

[9]  Jiming Hu,et al.  SURFACE-ENHANCED RAMAN SPECTROSCOPY OF SOME SCHIFF BASE COMPLEXES AND THEIR INTERACTION WITH DNA , 1999 .

[10]  D. Rideout,et al.  Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. , 1996, Gynecologic oncology.

[11]  M. Manfait,et al.  Specific molecular interactions of acridine drugs in complexes with topoisomerase II and DNA. SERS and resonance Raman study of m‐AMSA in comparison with o‐AMSA , 1995 .

[12]  E. Liang,et al.  Surface-enhanced Raman scattering of halide ions, pyridine and crystal violet on colloidal silver with near-infrared excitation: low-wavenumber vibrational modes , 1995 .

[13]  K. Nakamoto,et al.  Molecular distortion of distamycin on binding to DNA as revealed by Raman spectroscopy , 1990 .

[14]  W. Denny,et al.  Steric constraints for DNA binding and biological activity in the amsacrine series. , 1986, Anti-cancer drug design.